- Home
- LIQT vs NXL Comparison
LIQT vs NXL Comparison
Compare LIQT & NXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIQT
- NXL
- Stock Information
- Founded
- LIQT 2004
- NXL 2010
- Country
- LIQT Denmark
- NXL United States
- Employees
- LIQT N/A
- NXL N/A
- Industry
- LIQT Industrial Machinery/Components
- NXL Medical Specialities
- Sector
- LIQT Technology
- NXL Health Care
- Exchange
- LIQT Nasdaq
- NXL Nasdaq
- Market Cap
- LIQT 16.1M
- NXL 14.0M
- IPO Year
- LIQT N/A
- NXL 2022
- Fundamental
- Price
- LIQT $2.60
- NXL $0.81
- Analyst Decision
- LIQT Strong Buy
- NXL Strong Buy
- Analyst Count
- LIQT 2
- NXL 1
- Target Price
- LIQT $4.80
- NXL $5.00
- AVG Volume (30 Days)
- LIQT 20.6K
- NXL 2.9M
- Earning Date
- LIQT 11-13-2025
- NXL 11-07-2025
- Dividend Yield
- LIQT N/A
- NXL N/A
- EPS Growth
- LIQT N/A
- NXL N/A
- EPS
- LIQT N/A
- NXL N/A
- Revenue
- LIQT $15,459,242.00
- NXL $174,813.00
- Revenue This Year
- LIQT $36.89
- NXL $38.28
- Revenue Next Year
- LIQT $16.33
- NXL $185.71
- P/E Ratio
- LIQT N/A
- NXL N/A
- Revenue Growth
- LIQT N/A
- NXL 16.42
- 52 Week Low
- LIQT $1.34
- NXL $0.59
- 52 Week High
- LIQT $3.20
- NXL $4.49
- Technical
- Relative Strength Index (RSI)
- LIQT 63.09
- NXL 43.45
- Support Level
- LIQT $2.25
- NXL $0.79
- Resistance Level
- LIQT $2.88
- NXL $0.94
- Average True Range (ATR)
- LIQT 0.18
- NXL 0.07
- MACD
- LIQT 0.06
- NXL 0.00
- Stochastic Oscillator
- LIQT 72.00
- NXL 13.52
About LIQT LiqTech International Inc.
LiqTech International Inc is a clean technology company which provides technology for gas and liquid purification by manufacturing ceramic silicon carbide filters. The company is engaged in three businesses that are diesel particulate filters (DPF) for the control of soot from diesel engines, turnkey ceramic membranes systems, and complete water treatment plants. The company's product portfolio consists of ceramic silicon membranes for liquid filtration, diesel particulate filters, and kiln furniture. Its operating segment includes Water, Ceramics, and Plastics.
About NXL Nexalin Technology Inc.
Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.